Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 114

Sort by

Sort Order Select

Journal Articles

Second-Line Therapy for Immune Thrombocytopenia: Real-World Experience

Hasmik Nazaryan, Yang Liu, MS, Emily Sirotich, BS, Joanne M Duncan, MSc, Donald M. Arnold, MD

Blood (2019) 134 (Supplement_1): 2120.

https://doi.org/10.1182/blood-2019-128336

Published: 2019

Journal Articles

Overall Survival in Patients with Myelofibrosis Who Have Discontinued Ruxolitinib: A Literature Review

Derek Tang, PhD BSPharm, Ankush Taneja, Preety Rajora, Indeg Sly, Niall James Davison

Blood (2019) 134 (Supplement_1): 3457.

https://doi.org/10.1182/blood-2019-122904

Published: 2019

Journal Articles

Eltrombopag for Immune Thrombocytopenia Adult Patients in the Real-Life Practice in France. Interim Results of the Elextra Study

Guillaume Moulis, MD PhD, Manuela Rueter, MSc, Margaux Lafaurie, PharmD, Maryse Lapeyre-Mestre, MD PhD, Carmen investigators Group

Blood (2019) 134 (Supplement_1): 2372.

https://doi.org/10.1182/blood-2019-126000

Published: 2019

Journal Articles

Telomere Elongation and Clinical Improvement in Telomeropathy Patients: A Prospective Clinical Trial of Nandrolone in Telomeropathies

Diego V Clé, MD PhD, Luiz Fernando Catto, MD, Luiz Guilherme Darrigo, PhD, Elvis Valera, Fernanda Gutierrez-Rodrigues, PhD, Flavia S. Donaires, PhD, André Pinto, Renan C. Albino, Bárbara Santana, Jose Baddini-Martinez, MD PhD, Rodrigo T. Calado, MD PhD

Blood (2019) 134 (Supplement_1): 2501.

https://doi.org/10.1182/blood-2019-130844

Published: 2019

Journal Articles

Stanozolol and Danazol Have Different Effects on Hematopoiesis in Murine Model of Immune-Mediated Bone Marrow Failure

Hongmin Li, MD, Zhangbiao Long, MD, Bing Han, Zhao Wang, MD PhD

Blood (2019) 134 (Supplement_1): 2506.

https://doi.org/10.1182/blood-2019-126318

Published: 2019

Journal Articles

Positivity Rate of Systematic Bone Marrow Smear Above 60-Year-Old Patients with Newly Diagnosed Immune Thrombocytopenia to Screen for Associated Hematological Malignancy. Results from the French Prospective Multicenter Carmen Registry

Blood (2019) 134 (Supplement_1): 1083.

https://doi.org/10.1182/blood-2019-122821

Published: 2019

Journal Articles

Anabolic Steroids in Myelodysplastic Syndromes: A Systematic Review

Alejandro Garcia-Horton, MDFRCPC, Yashoda Valliere, Alejandro Lazo-Langner, MD MSc

Blood (2019) 134 (Supplement_1): 5425.

https://doi.org/10.1182/blood-2019-126806

Published: 2019

Journal Articles

A Feasibility Study of Biologically Focused Therapy for Myelodysplastic Syndrome Patients Refractory to Hypomethylating Agents

Michael A Spinner, Alexey Aleshin, MD MBA, Marianne A Santaguida, PhD, Steven A Schaffert, PhD, Taher Abbasi, MS, MBA, Jeffrey N Sanders, A Scott Patterson, MA, Diane Heiser, PhD, James L Zehnder, Peter L Greenberg, MD

Blood (2019) 134 (Supplement_1): 4239.

https://doi.org/10.1182/blood-2019-129473

Published: 2019

Journal Articles

Safety and Efficacy of Combined Ruxolitinib and Thalidomide in Patients with Myelofibrosis: A Phase II Study

Raajit K. Rampal, MD PhD, Srdan Verstovsek, MD PhD, Sean M. Devlin, PhD, Amber C. King, PharmD, BCOP, Eytan M. Stein, MD, Naveen Pemmaraju, MD, Michael J. Mauro, MD, Tapan M. Kadia, MD, Guillermo Montalban-Bravo, MD, Kelsey Alvarez, RN, Nicole Ard, Tawni Goodman, Bria Taylor, Prithviraj Bose, MD

Blood (2019) 134 (Supplement_1): 4163.

https://doi.org/10.1182/blood-2019-127661

Published: 2019

Journal Articles

Immune Thrombocytopenia in Very Elderly Patients: Particularities in Presentation and Management. Results from the Multicenter Prospective Carmen-France Registry

Aurélien Sokal, Thomas de Nadaï, Thibault Comont, Nicolas Limal, Marc Michel, Odile Beyne-Rauzy, Bertrand Godeau, MD, Daniel Adoue, Matthieu Mahévas, Guillaume Moulis, MD PhD, Carmen investigators Group

Blood (2019) 134 (Supplement_1): 1091.

https://doi.org/10.1182/blood-2019-126019

Published: 2019

Journal Articles

Risk Factors of Thrombosis in Adults with Primary Immune Thrombocytopenia. a French Nationwide Cohort Study

Guillaume Moulis, MD PhD, Bérangère Baricault, Charlotta Ekstrand, Margaux Lafaurie, PharmD, Christian Fynbo Christiansen, Marie Linder, Shahram Bahmanyar, Mette Nørgaard, MD PhD, Laurent Sailler, MD PhD, Maryse Lapeyre-Mestre, MD PhD

Blood (2018) 132 (Supplement 1): 3745.

https://doi.org/10.1182/blood-2018-99-112506

Published: 2018

Journal Articles

Clinical and Morphologic Predictors of Outcome in a Multicenter Cohort of ITP Patients Treated with Trombopoietin Analogues

Bruno Fattizzo, MD, Raffaella Pasquale, Monica Carpenedo, Silvia Cantoni, Giuseppe Auteri, MD, Doriana Gramegna, MD, Mariella D'adda, MD, Mariasanta Napolitano, Marco Ruggeri, MD, Sergio Siragusa, MD Professor, Giuseppe Rossi, Nicola Vianelli, MD, Wilma Barcellini, MD

Blood (2018) 132 (Supplement 1): 3764.

https://doi.org/10.1182/blood-2018-99-116627

Published: 2018

Journal Articles

Androgen Derivatives Improve Blood Counts and Elongate Telomere Length in Patients with Dyskeratosis Congenita

Martin Kirschner, MD, Monica Sofia Ventura Ferreira, PhD, Anne-Sophie Bouillon, MD, Marcin W. Wlodarski, MD PhD, Michaela Schwarz, MD, Stefan Balabanov, MD PhD, Stefan Wilop, MD, Steffen Koschmieder, MD, Jens P. Panse, MD, Tim H. Brümmendorf, MD, Fabian Beier, MD

Blood (2018) 132 (Supplement 1): 2585.

https://doi.org/10.1182/blood-2018-99-118197

Published: 2018

Journal Articles

Targeting Immune Dysregulation in Childhood Evans Syndrome

Amanda Bell Grimes, MD, Taylor Kim, MD, Susan E. Kirk, PA-C, Michele P. Lambert, MD, Rachael F. Grace, MD, Jenny M. Despotovic, DO, MS

Blood (2018) 132 (Supplement 1): 3564.

https://doi.org/10.1182/blood-2018-99-110734

Published: 2018

Journal Articles

Safety and Efficacy of Combined Ruxolitinib and Thalidomide in Patients with Myelofibrosis: Initial Results of a Phase II Study

Raajit K. Rampal, MD PhD, Srdan Verstovsek, MD PhD, Sean M Devlin, PhD, Eytan M. Stein, MD, Tapan M. Kadia, MD, Michael J. Mauro, MD, Naveen Pemmaraju, MD, Kelsey Alvarez, RN, Nicole Ard, Tawni Goodman, Kelly Marek, Prithviraj Bose, MD

Blood (2018) 132 (Supplement 1): 354.

https://doi.org/10.1182/blood-2018-99-114125

Published: 2018

Journal Articles

Somatic TERT promoter Mutations in a Broad Spectrum of Telomeropathies

Fernanda Gutierrez-Rodrigues, PhD, Flávia S Donaires, PhD, André Pinto, Alana Vicente, MD, Laura Dillon, PhD, Diego V Clé, MDPhD, Bárbara Santana, Maria del Pilar Fernandez Ibanez, Danielle M. Townsley, MD MSc, Sachiko Kajigaya, PhD, Christopher S. Hourigan, DPhil FACP FRCP, James N. Cooper, MD, Rodrigo T. Calado, MD PhD, Neal S. Young, MD

Blood (2018) 132 (Supplement 1): 539.

https://doi.org/10.1182/blood-2018-99-115430

Published: 2018

Journal Articles

Danazol Treatment for Thrombocytopenia in Lower-Risk Myelodysplastic Syndromes: A Pilot Real Life Experience

Marta Riva, Lara Crucitti, Emanuele Ravano, MD, Michele Nichelatti, PhD, Gianluigi Reda, MD, Cristina Fiamenghi, Roberto Cairoli, Alfredo Molteni, MD

Blood (2018) 132 (Supplement 1): 4375.

https://doi.org/10.1182/blood-2018-99-115283

Published: 2018

Journal Articles

Characterization of Philadelphia-Negative Myeloproliferative Neoplasms in the Chilean Public Health System: Multicentric Study

Ximena Valladares, MD, Christine Rojas, MD, Camila Peña, MD, Claudia Gajardo, MD, Maria Elena Cabrera, MD, Rodrigo Valenzuela, PhD, Virginia Monardes, Hernán López-Vidal, MD, Marcelo Abarca, MD, Pilar León, MD, Rocío Osorio, MD, Erika Pérez, MD, Pablo Soto, MD, Gabriel La Rocca, MD, Daniela Cardemil, MD, Marvila Intriago, MD, Vivianne Torres, MD

Blood (2018) 132 (Supplement 1): 5479.

https://doi.org/10.1182/blood-2018-99-117610

Published: 2018

Journal Articles

A Case Report of Refractory Immune Thrombocytopenia (ITP) Following Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplantation (HCT) for Myelodysplastic Syndrome (MDS) Successfully Treated with Off-Label Use of Daratumumab

Yazan Migdady, MD MSc, Ridhi Gupta, MBBS, Asiri Ediriwickrema, MD, Francisco Socola, MD, Sally Arai, MD, Beth A Martin, MD

Blood (2018) 132 (Supplement 1): 4976.

https://doi.org/10.1182/blood-2018-99-116560

Published: 2018

Journal Articles

Between a Rux and a Hard Place: Investigating Causes of Ruxolitinib Discontinuation, Salvage Treatment and Outcome in Myelofibrosis

Savan Shah, MD, Chetasi Talati, MD, Najla Al Ali, M.Sc, Eric Padron, MD, David A Sallman, MD, Kendra L. Sweet, MD, Jeffrey E. Lancet, MD, Alan F. List, MD, Kenneth S. Zuckerman, MD, Rami S. Komrokji, MD, Andrew Kuykendall, MD

Blood (2017) 130 (Supplement 1): 4186.

https://doi.org/10.1182/blood.V130.Suppl_1.4186.4186

Published: 2017

NARROW

Second-Line Therapy for Immune Thrombocytopenia: Real-World Experience

Overall Survival in Patients with Myelofibrosis Who Have Discontinued Ruxolitinib: A Literature Review

Eltrombopag for Immune Thrombocytopenia Adult Patients in the Real-Life Practice in France. Interim Results of the Elextra Study

Telomere Elongation and Clinical Improvement in Telomeropathy Patients: A Prospective Clinical Trial of Nandrolone in Telomeropathies

Stanozolol and Danazol Have Different Effects on Hematopoiesis in Murine Model of Immune-Mediated Bone Marrow Failure

Positivity Rate of Systematic Bone Marrow Smear Above 60-Year-Old Patients with Newly Diagnosed Immune Thrombocytopenia to Screen for Associated Hematological Malignancy. Results from the French Prospective Multicenter Carmen Registry

Anabolic Steroids in Myelodysplastic Syndromes: A Systematic Review

A Feasibility Study of Biologically Focused Therapy for Myelodysplastic Syndrome Patients Refractory to Hypomethylating Agents

Safety and Efficacy of Combined Ruxolitinib and Thalidomide in Patients with Myelofibrosis: A Phase II Study

Immune Thrombocytopenia in Very Elderly Patients: Particularities in Presentation and Management. Results from the Multicenter Prospective Carmen-France Registry

Risk Factors of Thrombosis in Adults with Primary Immune Thrombocytopenia. a French Nationwide Cohort Study

Clinical and Morphologic Predictors of Outcome in a Multicenter Cohort of ITP Patients Treated with Trombopoietin Analogues

Androgen Derivatives Improve Blood Counts and Elongate Telomere Length in Patients with Dyskeratosis Congenita

Targeting Immune Dysregulation in Childhood Evans Syndrome

Safety and Efficacy of Combined Ruxolitinib and Thalidomide in Patients with Myelofibrosis: Initial Results of a Phase II Study

Somatic TERT promoter Mutations in a Broad Spectrum of Telomeropathies

Danazol Treatment for Thrombocytopenia in Lower-Risk Myelodysplastic Syndromes: A Pilot Real Life Experience

Characterization of Philadelphia-Negative Myeloproliferative Neoplasms in the Chilean Public Health System: Multicentric Study

A Case Report of Refractory Immune Thrombocytopenia (ITP) Following Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplantation (HCT) for Myelodysplastic Syndrome (MDS) Successfully Treated with Off-Label Use of Daratumumab

Between a Rux and a Hard Place: Investigating Causes of Ruxolitinib Discontinuation, Salvage Treatment and Outcome in Myelofibrosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only